GlassScriptPhysician profile
Brittany D Griffith
NPI 1104464999
$8,240.84
in general payments reported to CMS, 2019-2025
40 companies · $1,633 in 2025
The $1,633 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,186 · 2022: $1,680 · 2023: $1,924 · 2024: $1,818 · 2025: $1,633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,358 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,357.64 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,500.98 | 2021-2025 | Breztri, Farxiga, Fasenra |
| Pfizer INC. | $1,176.28 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $746.00 | 2021-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $481.31 | 2021-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $430.36 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $381.86 | 2021-2025 | |
| Glaxosmithkline, LLC. | $376.21 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $349.04 | 2021-2025 | |
| Exact Sciences Corporation | $315.96 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $225.22 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $208.89 | 2021-2025 | Lifevest |
| Amarin Pharma, INC. | $185.38 | 2021-2023 | |
| Mylan Specialty L.P. | $165.39 | 2021-2024 | Yupelri |
| Abbvie INC. | $147.45 | 2023-2025 | |
| Verona Pharma, INC. | $145.93 | 2025 | Ohtuvayre |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $137.41 | 2021-2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $134.40 | 2023-2024 | Inpefa |
| Lundbeck LLC | $115.25 | 2022-2025 | Vyepti |
| Shield Therapeutics INC | $96.22 | 2024 | |
| Baxter Healthcare | $83.97 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Merck Sharp & Dohme LLC | $81.87 | 2024-2025 | Capvaxive, Gardasil 9, M-M-R II |
| Axsome Therapeutics, INC. | $72.40 | 2022-2024 | Sunosi |
| Paratek Pharmaceuticals, INC. | $71.29 | 2022-2023 | Nuzyra |
| Averitas Pharma INC. | $69.70 | 2023-2024 | Qutenza |
| Lilly USA, LLC | $63.97 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Dexcom, INC. | $62.58 | 2021-2024 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $60.79 | 2021-2022 | |
| Astellas Pharma US INC | $54.60 | 2023-2025 | Veozah, Myrbetriq |
| Biohaven Pharmaceutical Holding Company LTD. | $42.50 | 2022 | |
| Amgen INC. | $41.90 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.12 | 2021-2022 | |
| Tactile Systems Technology INC | $30.17 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Almatica Pharma LLC | $28.54 | 2021 | |
| Eisai INC. | $28.22 | 2021 | |
| Harmony Biosciences LLC | $18.34 | 2025 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Heartflow, INC. | $15.22 | 2024 | |
| Jazz Pharmaceuticals INC. | $13.84 | 2021 | |
| Phathom Pharmaceuticals, INC. | $13.17 | 2024 | Voquezna |
| Ambu INC. | $9.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.